Galvani, Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2
Ending by 2030
Jul 2030
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 23, 2026The maintenance fee for Method for coordinating medium voltage therapy for improving effectiveness of defibrillation therapy (US 9,061,164) comes due Dec 23, 2026. Unpaid by Jun 23, 2027, it lapses early.
- 1 fee due Mar 29, 2027The maintenance fee for Medium Voltage Therapy Applied as a Test of a Physiologic State (US 9,144,684) comes due Mar 29, 2027. Unpaid by Sep 29, 2027, it lapses early.
- 1 fee due Apr 27, 2027The maintenance fee for Arrhythmia electrotherapy device and method with provisions for inferring patient discomfort from evoked response (US 9,168,381) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,144,684 | Medium Voltage Therapy Applied as a Test of a Physiologic State In force · High confidence | In force | High confidence | |
| US 8,401,637 | Medium voltage therapy applications in treating cardiac arrest In force · From the USPTO record | In force | From the USPTO record | |
| US 9,480,851 | Multi-modal electrotherapy method and apparatus In force · From the USPTO record | In force | From the USPTO record | |
| US 9,061,164 | Method for coordinating medium voltage therapy for improving effectiveness of defibrillation therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 9,421,391 | Coordinated medium voltage therapy for improving effectiveness of defibrillation therapy In force · From the USPTO record | In force | From the USPTO record | |
| US 8,868,178 | Arrhythmia electrotherapy device and method with provisions for mitigating patient discomfort In force · From the USPTO record | In force | From the USPTO record | |
| US 9,168,381 | Arrhythmia electrotherapy device and method with provisions for inferring patient discomfort from evoked response In force · From the USPTO record | In force | From the USPTO record | |
| US 9,636,504 | Arrhythmia electrotheraphy device and method with provisions for mitigating patient discomfort In force · From the USPTO record | In force | From the USPTO record | |
| US 10,143,851 | Arrhythmia electrotherapy device and method with provisions for mitigating patient discomfort In force · From the USPTO record | In force | From the USPTO record | |
| US 10,238,884 | Cardiac-safe electrotherapy method and apparatus In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 11: 8 lapsed for an unpaid fee · 10 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 1 no status recorded